These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32364285)

  • 41. Methylation-mediated LINC00261 suppresses pancreatic cancer progression by epigenetically inhibiting c-Myc transcription.
    Liu S; Zheng Y; Zhang Y; Zhang J; Xie F; Guo S; Gu J; Yang J; Zheng P; Lai J; Yin L; Wang H
    Theranostics; 2020; 10(23):10634-10651. PubMed ID: 32929371
    [No Abstract]   [Full Text] [Related]  

  • 42. A novel long non-coding RNA ENST00000480739 suppresses tumour cell invasion by regulating OS-9 and HIF-1α in pancreatic ductal adenocarcinoma.
    Sun YW; Chen YF; Li J; Huo YM; Liu DJ; Hua R; Zhang JF; Liu W; Yang JY; Fu XL; Yan T; Hong J; Cao H
    Br J Cancer; 2014 Nov; 111(11):2131-41. PubMed ID: 25314054
    [TBL] [Abstract][Full Text] [Related]  

  • 43. PUM1 knockdown prevents tumor progression by activating the PERK/eIF2/ATF4 signaling pathway in pancreatic adenocarcinoma cells.
    Dai H; Shen K; Yang Y; Su X; Luo Y; Jiang Y; Shuai L; Zheng P; Chen Z; Bie P
    Cell Death Dis; 2019 Aug; 10(8):595. PubMed ID: 31395860
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LINC01133 promotes pancreatic ductal adenocarcinoma epithelial-mesenchymal transition mediated by SPP1 through binding to Arp3.
    Yang Y; Gong Y; Ding Y; Sun S; Bai R; Zhuo S; Zhang Z
    Cell Death Dis; 2024 Jul; 15(7):492. PubMed ID: 38987572
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The lncRNA ENSG00000254041.1 promotes cell invasiveness and associates with poor prognosis of pancreatic ductal adenocarcinoma.
    Chen B; Zhang Q; Wang X; Wang Y; Cui J; Zhuang H; Tang J
    Aging (Albany NY); 2020 Feb; 12(4):3647-3661. PubMed ID: 32090981
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascade.
    Kirtonia A; Pandey AK; Ramachandran B; Mishra DP; Dawson DW; Sethi G; Ganesan TS; Koeffler HP; Garg M
    Cell Mol Life Sci; 2022 Jun; 79(7):362. PubMed ID: 35699794
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of distinct long noncoding RNA transcriptional fingerprints in pancreatic ductal adenocarcinoma.
    Yu X; Lin Y; Sui W; Zou Y; Lv Z
    Cancer Med; 2017 Mar; 6(3):673-680. PubMed ID: 28220683
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The involvement of lncRNAs in the development and progression of pancreatic cancer.
    Duguang L; Jin H; Xiaowei Q; Peng X; Xiaodong W; Zhennan L; Jianjun Q; Jie Y
    Cancer Biol Ther; 2017 Dec; 18(12):927-936. PubMed ID: 29053398
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance.
    Jiang XY; Zhu QC; Zhang XJ; Duan T; Feng J; Sui XB; Sun XN; Mou YP
    Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):128-139. PubMed ID: 36543619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LncRNA FAM83H-AS1 promotes the malignant progression of pancreatic ductal adenocarcinoma by stabilizing FAM83H mRNA to protect β-catenin from degradation.
    Zhou M; Pan S; Qin T; Zhao C; Yin T; Gao Y; Liu Y; Zhang Z; Shi Y; Bai Y; Gong J; Guo X; Wang M; Qin R
    J Exp Clin Cancer Res; 2022 Sep; 41(1):288. PubMed ID: 36171592
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel antisense lncRNA NT5E promotes progression by modulating the expression of SYNCRIP and predicts a poor prognosis in pancreatic cancer.
    Zhang P; Cao M; Zhang Y; Xu L; Meng F; Wu X; Xia T; Chen Q; Shi G; Wu P; Chen L; Lu Z; Yin J; Cai B; Cao S; Miao Y; Jiang K
    J Cell Mol Med; 2020 Sep; 24(18):10898-10912. PubMed ID: 32770626
    [TBL] [Abstract][Full Text] [Related]  

  • 52. H19 promotes pancreatic cancer metastasis by derepressing let-7's suppression on its target HMGA2-mediated EMT.
    Ma C; Nong K; Zhu H; Wang W; Huang X; Yuan Z; Ai K
    Tumour Biol; 2014 Sep; 35(9):9163-9. PubMed ID: 24920070
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CCL18 promotes epithelial-mesenchymal transition, invasion and migration of pancreatic cancer cells in pancreatic ductal adenocarcinoma.
    Meng F; Li W; Li C; Gao Z; Guo K; Song S
    Int J Oncol; 2015 Mar; 46(3):1109-20. PubMed ID: 25502147
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Upregulation of macrophage migration inhibitory factor promotes tumor metastasis and correlates with poor prognosis of pancreatic ductal adenocarcinoma.
    Wang D; Wang R; Huang A; Fang Z; Wang K; He M; Xia JT; Li W
    Oncol Rep; 2018 Nov; 40(5):2628-2636. PubMed ID: 30226561
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pooled CRISPR screening in pancreatic cancer cells implicates co-repressor complexes as a cause of multiple drug resistance via regulation of epithelial-to-mesenchymal transition.
    Ramaker RC; Hardigan AA; Gordon ER; Wright CA; Myers RM; Cooper SJ
    BMC Cancer; 2021 May; 21(1):632. PubMed ID: 34049503
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The C/EBPβ-LINC01133 axis promotes cell proliferation in pancreatic ductal adenocarcinoma through upregulation of CCNG1.
    Huang CS; Chu J; Zhu XX; Li JH; Huang XT; Cai JP; Zhao W; Yin XY
    Cancer Lett; 2018 May; 421():63-72. PubMed ID: 29458145
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The long non-coding RNA HOTAIR affects the radiosensitivity of pancreatic ductal adenocarcinoma by regulating the expression of Wnt inhibitory factor 1.
    Jiang Y; Li Z; Zheng S; Chen H; Zhao X; Gao W; Bi Z; You K; Wang Y; Li W; Li L; Liu Y; Chen R
    Tumour Biol; 2016 Mar; 37(3):3957-67. PubMed ID: 26482614
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LncRNA CCAT1 participates in pancreatic ductal adenocarcinoma progression by forming a positive feedback loop with c-Myc.
    Cheng C; Liu Z; Liu D; Chen H; Wang Y; Sun B
    Carcinogenesis; 2024 Feb; 45(1-2):69-82. PubMed ID: 37936306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Upregulated long non-coding RNA SPRY4-IT1 predicts dismal prognosis for pancreatic ductal adenocarcinoma and regulates cell proliferation and apoptosis.
    Yao Y; Gao P; Chen L; Wang W; Zhang J; Li Q; Xu Y
    Gene; 2018 Jun; 659():52-58. PubMed ID: 29551494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
    Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
    Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.